Market Cap 18.73M
Revenue (ttm) 640,000.00
Net Income (ttm) -57.78M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -9,028.13%
Debt to Equity Ratio 0.00
Volume 26,724
Avg Vol 112,792
Day's Range N/A - N/A
Shares Out 41.61M
Stochastic %K 93%
Beta -1.35
Analysts Sell
Price Target $11.67

Latest News on RLYB

National Vision Releases 2023 Sustainability Report

Aug 27, 2024, 8:00 AM EDT - 8 months ago

National Vision Releases 2023 Sustainability Report

ACNT


Rallybio to Present at Upcoming Investor Conferences

Aug 27, 2024, 8:00 AM EDT - 8 months ago

Rallybio to Present at Upcoming Investor Conferences


Rallybio to Present at the 2024 Jones Healthcare Seaside Summit

Jul 9, 2024, 8:00 AM EDT - 10 months ago

Rallybio to Present at the 2024 Jones Healthcare Seaside Summit


Rallybio: Gearing Up To Be An Opportunity

Sep 15, 2023, 5:15 PM EDT - 1 year ago

Rallybio: Gearing Up To Be An Opportunity


Rallybio to Present at the Jefferies Healthcare Conference

Jun 1, 2023, 8:00 AM EDT - 2 years ago

Rallybio to Present at the Jefferies Healthcare Conference